Back to Search
MICHAEL VEEDER, MD
MD
Hematology & Oncology Physician
NPI: 1568463305IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
036-063948(IL)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1971
Research & Publications (6)
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group.
PMID 18470909·Cancer·2008
3-trial
Hematologic and cytogenetic spontaneous remission in acute monocytic leukemia (FAB M5b) with trisomy 8.
PMID 17235053·J Clin Oncol·2007
5-case
A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932.
PMID 16118507·Oncology·2005
3-trial
Effects of stimulant medication on cognitive performance of children with ADHD.
PMID 15965546·Clin Pediatr (Phila)·2005
4-observational
Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
PMID 15837967·J Clin Oncol·2005
3-trial
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.
PMID 15803016·Am J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8940 N WOOD SAGE RD
PEORIA, IL 61615 - Phone
- (309) 243-3000
Quick Facts
- NPI
- 1568463305
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 55
- Publications
- 6
Are you this provider?
Claim Your Profile